The Europe Flow Cytometry Market is expected to witness market growth of 7.9% CAGR during the forecast period (2022-2028).
Depending on where the light is gathered relative to the laser's path, these measurements are referred to as forwarding angle scatter (FSC) and side angle scatters (SSC). All of the fluorophores connected to the cell will be excited almost simultaneously by the laser's light, resulting in fluorescence emission. The flow cytometer's electronics unit processes all of this light once it has been collected by the detector. The cell is no longer required after traveling through the questioning point, thus the fluidics system transports it to the disposal container.
If this were a cell sorter, the cell is expected to now be transferred to a collection tube and utilized in subsequent experiments. Every fluorochrome has a wide range of fluorescence. The clash between fluorochromes can happen when more than one fluorochrome is utilized. Spectrum overlap refers to this circumstance. For instance, the light released by the fluorescein spans the same wavelength as it goes through the filter being used PE in the emission spectra for FITC and PE. By subtracting a portion of the FITC output from the PE indicators or vice versa, this spectral overlap is addressed.
The burden of cancer is rapidly surging in the region. In addition, according to the European Commission, in the European Union, 2.7 million people were given the disease diagnosis in 2020, and an additional 1.3 million people died from it. Cancer is a personal diagnosis that has significant effects on each patient, but it also has a profoundly negative impact on the lives of their family members. Currently, only 10% of the world's population lives in Europe, yet 25% of cancer cases do. By 2035, more than 24% more people in the EU will die from cancer, making it the top cause of death.
The Germany market dominated the Europe Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $494.1 million by 2028. The UK market is anticipated to grow a CAGR of 7% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 8.7% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
Depending on where the light is gathered relative to the laser's path, these measurements are referred to as forwarding angle scatter (FSC) and side angle scatters (SSC). All of the fluorophores connected to the cell will be excited almost simultaneously by the laser's light, resulting in fluorescence emission. The flow cytometer's electronics unit processes all of this light once it has been collected by the detector. The cell is no longer required after traveling through the questioning point, thus the fluidics system transports it to the disposal container.
If this were a cell sorter, the cell is expected to now be transferred to a collection tube and utilized in subsequent experiments. Every fluorochrome has a wide range of fluorescence. The clash between fluorochromes can happen when more than one fluorochrome is utilized. Spectrum overlap refers to this circumstance. For instance, the light released by the fluorescein spans the same wavelength as it goes through the filter being used PE in the emission spectra for FITC and PE. By subtracting a portion of the FITC output from the PE indicators or vice versa, this spectral overlap is addressed.
The burden of cancer is rapidly surging in the region. In addition, according to the European Commission, in the European Union, 2.7 million people were given the disease diagnosis in 2020, and an additional 1.3 million people died from it. Cancer is a personal diagnosis that has significant effects on each patient, but it also has a profoundly negative impact on the lives of their family members. Currently, only 10% of the world's population lives in Europe, yet 25% of cancer cases do. By 2035, more than 24% more people in the EU will die from cancer, making it the top cause of death.
The Germany market dominated the Europe Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $494.1 million by 2028. The UK market is anticipated to grow a CAGR of 7% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 8.7% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Application- Academic & Clinical
- Diagnostic
- Commercial Organizations
- Hospitals
- Academic Institutions
- Medical Schools & Clinical Testing Labs
- Others
- Cell Based
- Bead Based
- Instruments
- Reagents & Consumables
- Software
- Services
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Flow Cytometry Market by Application
Chapter 5. Europe Flow Cytometry Market by End User
Chapter 6. Europe Flow Cytometry Market by Technology
Chapter 7. Europe Flow Cytometry Market by Component
Chapter 8. Europe Flow Cytometry Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
Methodology
LOADING...
